RNNarrative ReviewJournal of perioperative practice2025

Additional doses of prophylactic antibiotics post-arthroplasty: Are there any benefits?

James Adeosun, Essam Rama, Azeem Thahir and 1 others

PMID 38877723

WHAT IT FOUND

For most patients after hip or knee replacement, extra antibiotic doses after surgery did not show benefit.

Adding vancomycin to cefazolin increased acute kidney injury from 8% to 13%.

Key findings

01In a large study of American veterans, increasing antibiotic duration after joint arthroplasty did not improve surgical site infection rates, and 502 of 38,675 patients had a surgical site infection across different durations.

02Adding vancomycin to cefazolin after total joint arthroplasty increased acute kidney injury from 8% to 13%, without evidence of significantly reducing infection rates.

03Some studies reported lower infection rates with extended or added antibiotics in selected high-risk situations, but the review says such evidence cannot prove significance due to low power.

STILL TO COME

How it was doneWhat they foundWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

This is a narrative review, not a systematic review, and it does not report how studies were searched, selected, or appraised. Many cited studies are retrospective, underpowered, or have short follow-up, so they cannot reliably prove benefit or harm. The evidence for extra doses in high-risk patients, MRSA risk, or long operations is limited and comes from selected groups. The review does not provide a patient-level dataset or a single primary outcome for this question.

Declared interests

The authors declared no potential conflicts of interest.

The easy way to misread this

Do not conclude that extra postoperative antibiotics are harmless because infection rates are low. The review reports increased acute kidney injury and C. difficile risk with longer regimens.

Read it on PubMed →